These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38464372)

  • 1. Serum tumor markers expression (CA199, CA242, and CEA) and its clinical implications in type 2 diabetes mellitus.
    Meng M; Shi LL
    World J Diabetes; 2024 Feb; 15(2):232-239. PubMed ID: 38464372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Cancer Patients.
    Chen Y; Gao SG; Chen JM; Wang GP; Wang ZF; Zhou B; Jin CH; Yang YT; Feng XS
    Cell Biochem Biophys; 2015 Apr; 71(3):1287-91. PubMed ID: 25486903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer.
    Wang YF; Feng FL; Zhao XH; Ye ZX; Zeng HP; Li Z; Jiang XQ; Peng ZH
    World J Gastroenterol; 2014 Apr; 20(14):4085-92. PubMed ID: 24744600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
    Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
    Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of multi-detector computed tomography combined with serum tumor markers in diagnosis, preoperative, and prognostic evaluation of pancreatic cancer.
    Su J; Wang Y; Shao H; You X; Li S
    World J Surg Oncol; 2022 Sep; 20(1):323. PubMed ID: 36175918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The correlation between pre-operative serum tumor markers and lymph node metastasis in gastric cancer patients undergoing curative treatment.
    Li F; Li S; Wei L; Liang X; Zhang H; Liu J
    Biomarkers; 2013 Nov; 18(7):632-7. PubMed ID: 24066812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of microRNA-200 expression in peripheral blood-derived extracellular vesicles in early-stage non-small cell lung cancer.
    Liu L; Zhang F; Niu D; Guo X; Lei T; Liu H
    Clin Exp Med; 2024 Sep; 24(1):214. PubMed ID: 39249157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of serum CA199 levels with glycemic control and microvascular complications in patients with type 2 diabetes mellitus.
    Tong W; Gao H; Wei X; Mao D; Zhang L; Chen Q; Zhang Z; Li Y
    Am J Transl Res; 2021; 13(4):3302-3308. PubMed ID: 34017502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum CA724 has no diagnostic value for gastrointestinal tumors.
    Cao H; Zhu L; Li L; Wang W; Niu X
    Clin Exp Med; 2023 Oct; 23(6):2433-2442. PubMed ID: 36920593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoembryonic antigen, carbohydrate antigen 199 and carbohydrate antigen 724 in gastric cancer and their relationship with clinical prognosis.
    Wang R; Zuo CL; Zhang R; Zhu LM
    World J Gastrointest Oncol; 2023 Aug; 15(8):1475-1485. PubMed ID: 37663935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between tumor markers and type 2 diabetes mellitus complications and their related influencing factors.
    Cai R; Kong Q; Wang Z; Gao Z; Huo Y
    Ann Palliat Med; 2022 Jan; 11(1):58-67. PubMed ID: 35144398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the expression of serum markers CA242, CA199, CA125, CEA, TNF-α and TSGF after cryosurgery in pancreatic cancer patients.
    Zhou G; Niu L; Chiu D; He L; Xu K
    Biotechnol Lett; 2012 Jul; 34(7):1235-41. PubMed ID: 22456901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of blood tumor markers in predicting metastasis and local recurrence after curative resection of colon cancer.
    Peng Y; Zhai Z; Li Z; Wang L; Gu J
    Int J Clin Exp Med; 2015; 8(1):982-90. PubMed ID: 25785084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in serum tumor markers in type 2 diabetes mellitus with microalbuminuria.
    Chen L; Du S; Li YB; Su Q; Zhang J; Zhang H
    Front Endocrinol (Lausanne); 2023; 14():1247099. PubMed ID: 38130399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.
    Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ
    Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum tumor markers: Can they clinically implicate in type 2 diabetes mellitus?
    Reddy KS; Pandiaraj IP; Gaur A; Varatharajan S
    World J Diabetes; 2024 Jul; 15(7):1648-1650. PubMed ID: 39099811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SERUM LEVELS OF CARCINOEMBRYONIC ANTIGEN IN PATIENTS WITH TYPE 2 DIABETES.
    Zayed AA; Beano AM; Amer FN; Maslamani JM; Zmaili MA; Al-Khudary TH; Momani MS; Yousef AF
    Endocr Pract; 2016 Nov; 22(11):1310-1318. PubMed ID: 27482614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic Value of Serum Pepsinogen Ⅰ/Pepsinogen Ⅱ Combined with Tumor Markers for
    Wang SS; Guo ZP; Zhao XY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Jan; 54(1):186-191. PubMed ID: 36647665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of iron overload on the level of carbohydrate antigen 199 in type 2 diabetes mellitus].
    Shang XJ; Du XM; Fang T; Zhang R; Tian FS
    Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(22):1722-1726. PubMed ID: 31216819
    [No Abstract]   [Full Text] [Related]  

  • 20. Application values of detection of serum CA199, CA242 and CA50 in the diagnosis of pancreatic cancer.
    Lei XF; Jia SZ; Ye J; Qiao YL; Zhao GM; Li XH; Chang H
    J Biol Regul Homeost Agents; 2017; 31(2):383-388. PubMed ID: 28685541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.